We are live on ! Find out more
ALIM

Alimera Sciences

Delisted

ALIM was delisted on the 13th of September, 2024.

43 hedge funds and large institutions have $35.9M invested in Alimera Sciences in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

29% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 7

16% more funds holding

Funds holding: 3743 (+6)

1% more capital invested

Capital invested by funds: $35.5M → $35.9M (+$379K)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
43
Holders Change
+6
Holders Change %
+16.22%
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
9
Reduced
7
Closed
2
Calls
Puts
Net Calls
Net Calls Change

ALIM Hedge Fund Activity: Q3 2018 in Review

43 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q3 2018, worth a combined $35.9M — up 1.1% from $35.5M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ALIM positions and 2 closed out — a net gain of 6 holders — while 9 added to existing stakes and 7 trimmed.

The largest buyer was B. Riley Financial, opening a new position worth an estimated $463K. The largest seller was Acuta Capital Partners, cutting an estimated $717K.

  • 43 institutional investors held Alimera Sciences (ALIM) as of Q3 2018, up from 37 in Q2 2018.
  • Funds reported $35.9M of Alimera Sciences stock for Q3 2018, up 1.1% quarter-over-quarter.
  • 8 funds opened new Alimera Sciences positions in Q3 2018 and 2 closed out, a net change of +6 holders.
  • The largest Alimera Sciences buyer in Q3 2018 was B. Riley Financial, an estimated $463K added.
  • The largest Alimera Sciences seller in Q3 2018 was Acuta Capital Partners, an estimated $717K sold.

Based on aggregated 13F filings for Q3 2018.